FindTrial
Sign In

Bioequivalence of One Tablet of Gliclazide MR 90 mg (S005190) and One and a Half Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participants under Fed Conditions.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519567-18-00
Acronym
S005190-205
Enrollment
36
Registered
2025-03-17
Start date
2025-06-02
Completion date
2025-07-17
Last updated
2025-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition.

Interventions

None listed

Sponsors

Institut De Recherches Internationales Servier IRIS
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026